Basiliximab Intravenous and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Basiliximab Intravenous and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: basiliximab
Brand name: Simulect
Synonyms: Basiliximab
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Basiliximab Intravenous-Insulin degludec Subcutaneous
- Basiliximab Intravenous-Insulin detemir
- Basiliximab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Basiliximab Intravenous-Insulin Detemir (Vials)
- Basiliximab Intravenous-Insulin detemir Subcutaneous
- Basiliximab Intravenous-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Bavencio
- Insulin degludec and liraglutide Subcutaneous-Baxdela
- Insulin degludec and liraglutide Subcutaneous-Baxdela (Delafloxacin Injection)
- Insulin degludec and liraglutide Subcutaneous-Baxdela (Delafloxacin Tablets)
- Insulin degludec and liraglutide Subcutaneous-Baxdela Intravenous
- Insulin degludec and liraglutide Subcutaneous-Baycadron